Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
Jonathan L. Finlay(The Ohio State University), Roger J. Packer(Children's Hospital of Philadelphia), Bruce H. Cohen(Akron Children's Hospital), Robert A. Zimmerman(Children's Hospital Colorado), Richard E. Harris(University of California, Irvine), Charles S. August(University of Pennsylvania), M. C. Wong(Memorial Sloan Kettering Cancer Center), Jan‐Stephan Sanders(Tufts University), Stewart Goldman(St Nicholas Hospital), James H. Garvin(Columbia University Irving Medical Center), J. Russell Geyer(St. Jude Children's Research Hospital), James M. Boyett(University of Illinois Chicago), A. J. Yates(Memorial Sloan Kettering Cancer Center), Mitchell S. Cairo(New York Medical College), P Stanley(Memorial Sloan Kettering Cancer Center), Bruce Bostrom(Minnesota West Community & Technical College)
Cited by 203
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
|Journal of Clinical Oncology|2008|794
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity
|Arthritis & Rheumatism|2010|644